CLDI Company Profile and Key Details

AMEX : CLDI

Calidi Biotherapeutics

$1.64

0.1472+9.86%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Calidi Biotherapeutics, Inc. (CLDI) stock surged +9.86%, trading at $1.64 on AMEX, up from the previous close of $1.49. The stock opened at $1.93, fluctuating between $1.53 and $1.93 in the recent session.

Stock Snapshot

1.4928

Prev. Close

755.12K

Market Cap

1.53

Day Low

-0.32

P/E Ratio

-5.2

EPS (TTM)

N/A

Cash Flow per Share

1.93

Open

460.44K

Number of Shares

1.93

Day High

93.64%

Free Float in %

N/A

Book Value

449.88K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 31, 2026	1.93	1.93	1.53	1.64	454.36K
Jul 30, 2026	1.61	1.62	1.49	1.49	144.22K
Jul 29, 2026	1.61	1.62	1.48	1.49	146.61K
Jul 28, 2026	1.72	1.75	1.61	1.72	146.32K
Jul 27, 2026	1.60	1.90	1.55	1.75	455.75K
Jul 24, 2026	1.69	1.77	1.52	1.60	2.49M
Jul 23, 2026	1.66	1.77	1.57	1.68	3.36M
Jul 22, 2026	1.52	1.76	1.52	1.69	172.57K
Jul 21, 2026	1.60	1.66	1.55	1.59	257.3K
Jul 20, 2026	1.99	2.00	1.84	1.85	179.33K
Jul 17, 2026	1.86	2.00	1.82	1.90	96.35K
Jul 16, 2026	1.96	2.04	1.83	1.85	90.51K
Jul 15, 2026	1.92	2.00	1.88	1.97	92.36K
Jul 14, 2026	2.10	2.13	1.83	1.95	189.19K
Jul 13, 2026	2.21	2.28	2.02	2.12	146.8K
Jul 10, 2026	2.37	2.38	2.20	2.25	80.61K
Jul 09, 2026	2.29	2.40	2.28	2.40	103.14K
Jul 08, 2026	2.24	2.30	2.19	2.27	60.44K
Jul 07, 2026	2.40	2.40	2.16	2.30	120.51K
Jul 06, 2026	2.38	2.44	2.29	2.40	131.78K

Contact Details

San Diego, CA 92121

United States

https://calidibio.com 858 794 9600

About Company

Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, dedicated to developing advanced immunotherapies for various cancers. The company's innovative approach centers on utilizing powerful, allogeneic (donor-derived) stem cells as specialized carriers for anti-tumor agents. This technology is being advanced to address a range of oncological conditions, including aggressive brain tumors (high-grade gliomas) and other solid malignancies. Calidi's proprietary cell-based delivery systems are expertly designed to safeguard, amplify, and boost the therapeutic effects of oncolytic viruses. This strategic delivery method aims to achieve superior treatment efficacy and enhance patient safety. The company's clinical pipeline features two primary candidates: NeuroNova, which employs allogeneic neural stem cells loaded with an oncolytic adenovirus specifically for the treatment of high-grade gliomas; and SuperNova, which utilizes allogeneic adipose-derived mesenchymal stem cells to deliver the tumor-selective CAL1 oncolytic vaccinia virus for advanced metastatic solid tumors. Established in 2014, Calidi Biotherapeutics operates out of San Diego, California.

Stock Peers

PTHS

2.41+9.18%

Pelthos Therapeutics Inc.$28.66 AGE

-1.5-11.90%

AgeX Therapeutics, Inc.$11.10 CYBN

0.1+1.22%

Cybin Inc.$8.28 NRXS

-0.03-0.48%

NeurAxis, Inc.$6.25 ARMP

-0.24-5.02%

Armata Pharmaceuticals, Inc.$4.54 CANF

-0.13-3.96%

Can-Fite BioPharma Ltd.$3.15 PLX

0.1+4.41%

Protalix BioTherapeutics, Inc.$2.37 SER

-0.04-1.96%

Serina Therapeutics, Inc.$2.00 OSTX

-0.04-2.56%

OS Therapies Incorporated$1.52 NNVC

-0.03-1.94%

NanoViricides, Inc.$1.52

Frequently Asked Questions

What is the current Calidi Biotherapeutics, Inc. (CLDI) stock price?

Calidi Biotherapeutics, Inc. (AMEX: CLDI) stock price is $1.64 in the last trading session. During the trading session, CLDI stock reached the peak price of $1.93 while $1.53 was the lowest point it dropped to. The percentage change in CLDI stock occurred in the recent session was 9.86% while the dollar amount for the price change in CLDI stock was $0.15.

CLDI's industry and sector of operation?

The AMEX listed CLDI is part of Biotechnology industry that operates in the broader Healthcare sector. Calidi Biotherapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CLDI?

No Data

How CLDI did perform over past 52-week?

CLDI's closing price is 10.57% higher than its 52-week low of $1.48 where as its distance from 52-week high of $117.12 is -98.6%.

How many employees does CLDI have?

Number of CLDI employees currently stands at 29.

Link for CLDI official website?

Official Website of CLDI is: https://calidibio.com

How do I contact CLDI?

CLDI could be contacted at phone 858 794 9600 and can also be accessed through its website. CLDI operates from 4475 Executive Drive, San Diego, CA 92121, United States.

How many shares of CLDI are traded daily?

CLDI stock volume for the day was 449.88K shares. The average number of CLDI shares traded daily for last 3 months was 307.46K.

What is the market cap of CLDI currently?

The market value of CLDI currently stands at $755.12K with its latest stock price at $1.64 and 460.44K of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	29
Beta	1.3
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

Employees	29
Beta	1.3
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

CLDI Company Profile and Key Details

Calidi Biotherapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Shareholding & Insider Activity

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics